Multiple Sclerosis Market Forecast by Datamonitor Now Available at ReportsandReports
Sales of multiple sclerosis disease-modifying therapies exceeded $6.0 billion in 2008 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).
Dallas, TX, August 13, 2010 --(PR.com)-- ReportsandReports Announce it Will Carry Multiple Sclerosis Market Forecast Market Research Report in its Store.
Browse the complete Report on: http://www.reportsandreports.com/market-reports/multiple-sclerosis-market-forecast/
Sales of multiple sclerosis disease-modifying therapies exceeded $6.0 billion in 2008 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK). Datamonitor anticipates the combination of continuing strong historical growth dynamics and the uptake of the first oral therapies to result in the market value peaking at $8.4 billion in 2013 before the advent of biosimilars.
Reasons to Purchase
- Understand when late-stage pipeline products will launch and what impact these will have on the market during the forecast period 2008 to 2018
- Assess the impact of events, such as patent expiries and new product launches, on the multiple sclerosis-specific sales of key brand name products
- Quantify the size of the seven major markets from 2008 to 2018
Browse all Database/Market Forecast at http://www.reportsandreports.com/market-research/Database-market-forecast/
Browse all Datamonitor at http://www.reportsandreports.com/Publishers/datamonitor
Browse Latest Reports at: http://www.reportsandreports.com/LatestReport.aspx
Related Reports:
Central Nervous System Multiple Sclerosis Therapy Area Pipeline Report
http://www.reportsandreports.com/market-reports/central-nervous-system-multiple-sclerosis-therapy-area-pipeline-r/
Pipeline Insight: Multiple Sclerosis - Risk-benefit ratio under the spotlight for potent pipeline drugs
http://www.reportsandreports.com/market-reports/pipeline-insight-multiple-sclerosis-risk-benefit-ratio-under-t/
Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016
http://www.reportsandreports.com/market-reports/amyotrophic-lateral-sclerosis-lou-gehrigs-drug-pipeline-anal/
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://www.reportsandreports.com/
http://reportsnreports.wordpress.com/
###
Browse the complete Report on: http://www.reportsandreports.com/market-reports/multiple-sclerosis-market-forecast/
Sales of multiple sclerosis disease-modifying therapies exceeded $6.0 billion in 2008 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK). Datamonitor anticipates the combination of continuing strong historical growth dynamics and the uptake of the first oral therapies to result in the market value peaking at $8.4 billion in 2013 before the advent of biosimilars.
Reasons to Purchase
- Understand when late-stage pipeline products will launch and what impact these will have on the market during the forecast period 2008 to 2018
- Assess the impact of events, such as patent expiries and new product launches, on the multiple sclerosis-specific sales of key brand name products
- Quantify the size of the seven major markets from 2008 to 2018
Browse all Database/Market Forecast at http://www.reportsandreports.com/market-research/Database-market-forecast/
Browse all Datamonitor at http://www.reportsandreports.com/Publishers/datamonitor
Browse Latest Reports at: http://www.reportsandreports.com/LatestReport.aspx
Related Reports:
Central Nervous System Multiple Sclerosis Therapy Area Pipeline Report
http://www.reportsandreports.com/market-reports/central-nervous-system-multiple-sclerosis-therapy-area-pipeline-r/
Pipeline Insight: Multiple Sclerosis - Risk-benefit ratio under the spotlight for potent pipeline drugs
http://www.reportsandreports.com/market-reports/pipeline-insight-multiple-sclerosis-risk-benefit-ratio-under-t/
Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016
http://www.reportsandreports.com/market-reports/amyotrophic-lateral-sclerosis-lou-gehrigs-drug-pipeline-anal/
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://www.reportsandreports.com/
http://reportsnreports.wordpress.com/
###
Contact
ReportsandReports
Akshata Patil
+1-888-989-8004
http://www.reportsandreports.com/
Akshata Patil
+1-888-989-8004
http://www.reportsandreports.com/
Contact
Categories